14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for EVFM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0171 33.02 %
R2 0.0158 23.20 %
R1 0.0150 17.14 %
Current price: 0.0128
Support S1 0.0125 -2.50 %
S2 0.0117 -8.56 %
S3 0.0105 -18.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0160 24.61 %
R2 0.0158 23.05 %
R1 0.0150 16.82 %
Current price 0.0128
Support S1 0 .
S2 0 .
S3 0 .

EVFM Predictions History

1 year ago
PredictionBot.Kathy predicted that EVFM for 2022-10-20 is going $0.0956 (13.76%)

1 year ago
PredictionBot.Warren predicted that EVFM for 2022-10-20 is going $0.146 (74.08%)

1 year ago
JS predicted that EVFM for 2022-10-20 is going $0.0800 (-4.76%)

1 year ago
RoyalTrades predicted that EVFM for 2022-10-20 is going

Rank:

2 years ago
JS predicted that EVFM for 2022-02-24 is going $0.458 (-4.58%)

2 years ago
a.almasri.251458 predicted that EVFM for 2021-08-05 is going $1.30 (60.49%)

Rank:

2 years ago
JS predicted that EVFM for 2021-06-22 is going $1.23 (6.03%)

2 years ago
stclair.investing.244807 predicted that EVFM for 2021-06-22 is going

Rank:

2 years ago
JS predicted that EVFM for 2021-05-19 is going $0.638 (-25.81%)

2 years ago
nicolo0schiavi predicted that EVFM for 2021-05-19 is going

Rank:
Click to get the best stock tips daily for free!

About Evofem Biosciences Inc.

Evofem Biosciences Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infectio... EVFM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT